{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:50:16Z","timestamp":1790635816016,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T00:00:00Z","timestamp":1452556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Princess Alexandra Hospital Private Practice Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00262-015-1788-z","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T01:53:37Z","timestamp":1452563617000},"page":"213-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Galectin-1 is associated with poor prognosis in patients with cutaneous head and neck cancer with perineural spread"],"prefix":"10.1007","volume":"65","author":[{"given":"Sharad","family":"Chawla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leesa F.","family":"Wockner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan L. J.","family":"Lambie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P. C.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"Leggatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict J.","family":"Panizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,12]]},"reference":[{"issue":"4","key":"1788_CR1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.fsc.2012.07.004","volume":"20","author":"BO Cakir","year":"2012","unstructured":"Cakir BO, Adamson P, Cingi C (2012) Epidemiology and economic burden of nonmelanoma skin cancer. Facial Plast Surg Clin North Am 20(4):419\u2013422. doi: 10.1016\/j.fsc.2012.07.004","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"11","key":"1788_CR2","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hed.23509","volume":"36","author":"B Panizza","year":"2013","unstructured":"Panizza B, Warren TA, Solares CA, Boyle GM, Lambie D, Brown I (2013) Histopathological features of clinical perineural invasion of cutaneous squamous cell carcinoma of the head and neck and the potential implications for treatment. Head Neck 36(11):1611\u20131618. doi: 10.1002\/hed.23509","journal-title":"Head Neck"},{"issue":"5","key":"1788_CR3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/0194599811434897","volume":"146","author":"CA Solares","year":"2012","unstructured":"Solares CA, Lee K, Parmar P, O\u2019Rourke P, Panizza B (2012) Epidemiology of clinical perineural invasion in cutaneous squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 146(5):746\u2013751. doi: 10.1177\/0194599811434897","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"1788_CR4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2010.09.040","volume":"82","author":"C Lin","year":"2012","unstructured":"Lin C, Tripcony L, Keller J, Poulsen M, Martin J, Jackson J, Dickie G (2012) Perineural infiltration of cutaneous squamous cell carcinoma and basal cell carcinoma without clinical features. Int J Radiat Oncol Biol Phys 82(1):334\u2013340. doi: 10.1016\/j.ijrobp.2010.09.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1788_CR5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00041327-199709000-00005","volume":"17","author":"MW Hove ten","year":"1997","unstructured":"ten Hove MW, Glaser JS, Schatz NJ (1997) Occult perineural tumor infiltration of the trigeminal nerve. Diagnostic considerations. J Neuroophthalmol 17(3):170\u2013177","journal-title":"J Neuroophthalmol"},{"key":"1788_CR6","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hed.21986","volume":"34","author":"B Panizza","year":"2011","unstructured":"Panizza B, Solares CA, Redmond M et al (2011) Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck. Head Neck 34:1622\u20131627","journal-title":"Head Neck"},{"issue":"4","key":"1788_CR7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00280-008-0881-9","volume":"63","author":"F Mbeunkui","year":"2009","unstructured":"Mbeunkui F, Johann DJ Jr (2009) Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol 63(4):571\u2013582. doi: 10.1007\/s00280-008-0881-9","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"1788_CR8","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.bbapap.2013.01.029","volume":"1834","author":"TB Schaaij-Visser","year":"2013","unstructured":"Schaaij-Visser TB, de Wit M, Lam SW, Jimenez CR (2013) The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context. Biochim Biophys Acta 1834(11):2242\u20132258. doi: 10.1016\/j.bbapap.2013.01.029","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"1788_CR9","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbapap.2013.03.014","volume":"1834","author":"JL Paltridge","year":"2013","unstructured":"Paltridge JL, Belle L, Khew-Goodall Y (2013) The secretome in cancer progression. Biochim Biophys Acta 1834(11):2233\u20132241. doi: 10.1016\/j.bbapap.2013.03.014","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1788_CR10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ctrv.2013.07.007","volume":"40","author":"L Astorgues-Xerri","year":"2014","unstructured":"Astorgues-Xerri L, Riveiro ME, Tijeras-Raballand A, Serova M, Neuzillet C, Albert S, Raymond E, Faivre S (2014) Unraveling galectin-1 as a novel therapeutic target for cancer. Cancer Treat Rev 40(2):307\u2013319. doi: 10.1016\/j.ctrv.2013.07.007","journal-title":"Cancer Treat Rev"},{"issue":"8\u20139","key":"1788_CR11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10719-012-9379-0","volume":"29","author":"F Cedeno-Laurent","year":"2012","unstructured":"Cedeno-Laurent F, Dimitroff CJ (2012) Galectins and their ligands: negative regulators of anti-tumor immunity. Glycoconj J 29(8\u20139):619\u2013625. doi: 10.1007\/s10719-012-9379-0","journal-title":"Glycoconj J"},{"key":"1788_CR12","doi-asserted-by":"crossref","first-page":"e29103","DOI":"10.4161\/tisb.29103","volume":"2","author":"M Viguier","year":"2014","unstructured":"Viguier M, Advedissian T, Delacour D, Poirier F, Deshayes F (2014) Galectins in epithelial functions. Tissue Barriers 2:e29103. doi: 10.4161\/tisb.29103","journal-title":"Tissue Barriers"},{"issue":"2","key":"1788_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clim.2011.09.011","volume":"142","author":"F Cedeno-Laurent","year":"2012","unstructured":"Cedeno-Laurent F, Dimitroff CJ (2012) Galectin-1 research in T cell immunity: past, present and future. Clin Immunol 142(2):107\u2013116. doi: 10.1016\/j.clim.2011.09.011","journal-title":"Clin Immunol"},{"key":"1788_CR14","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S1462399408000719","volume":"10","author":"RY Yang","year":"2008","unstructured":"Yang RY, Rabinovich GA, Liu FT (2008) Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 10:e17. doi: 10.1017\/S1462399408000719","journal-title":"Expert Rev Mol Med"},{"issue":"5","key":"1788_CR15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. doi: 10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"9","key":"1788_CR16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2217\/imt.14.58","volume":"6","author":"HA Schlosser","year":"2014","unstructured":"Schlosser HA, Theurich S, Shimabukuro-Vornhagen A, Holtick U, Stippel DL, Bergwelt-Baildon M (2014) Overcoming tumor-mediated immunosuppression. Immunotherapy 6(9):973\u2013988. doi: 10.2217\/imt.14.58","journal-title":"Immunotherapy"},{"issue":"2","key":"1788_CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.coi.2010.02.006","volume":"22","author":"G Bindea","year":"2010","unstructured":"Bindea G, Mlecnik B, Fridman WH, Pages F, Galon J (2010) Natural immunity to cancer in humans. Curr Opin Immunol 22(2):215\u2013222. doi: 10.1016\/j.coi.2010.02.006","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"1788_CR18","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-06-4806","volume":"67","author":"J Galon","year":"2007","unstructured":"Galon J, Fridman WH, Pages F (2007) The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. Cancer Res 67(5):1883\u20131886. doi: 10.1158\/0008-5472.CAN-06-4806","journal-title":"Cancer Res"},{"issue":"4","key":"1788_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.oraloncology.2007.03.004","volume":"44","author":"WF Chiang","year":"2008","unstructured":"Chiang WF, Liu SY, Fang LY, Lin CN, Wu MH, Chen YC, Chen YL, Jin YT (2008) Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma. Oral Oncol 44(4):325\u2013334. doi: 10.1016\/j.oraloncology.2007.03.004","journal-title":"Oral Oncol"},{"issue":"4","key":"1788_CR20","first-page":"983","volume":"21","author":"YM Ding","year":"2009","unstructured":"Ding YM, Dong JH, Chen LL, Zhang HD (2009) Increased expression of galectin-1 is associated with human oral squamous cell carcinoma development. Oncol Rep 21(4):983\u2013987","journal-title":"Oncol Rep"},{"issue":"4","key":"1788_CR21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.prp.2011.02.004","volume":"207","author":"PM Alves","year":"2011","unstructured":"Alves PM, Godoy GP, Gomes DQ, Medeiros AM, de Souza LB, da Silveira EJ, Vasconcelos MG, Queiroz LM (2011) Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue. Pathol Res Pract 207(4):236\u2013240. doi: 10.1016\/j.prp.2011.02.004","journal-title":"Pathol Res Pract"},{"issue":"2","key":"1788_CR22","first-page":"495","volume":"24","author":"CE Tang","year":"2010","unstructured":"Tang CE, Tan T, Li C, Chen ZC, Ruan L, Wang HH, Su T, Zhang PF, Xiao ZQ (2010) Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis. Oncol Rep 24(2):495\u2013500","journal-title":"Oncol Rep"},{"issue":"3\u20134","key":"1788_CR23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2119\/molmed.2009.00119","volume":"16","author":"D Spano","year":"2010","unstructured":"Spano D, Russo R, Di Maso V, Rosso N, Terracciano LM, Roncalli M, Tornillo L, Capasso M, Tiribelli C, Iolascon A (2010) Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness. Mol Med 16(3\u20134):102\u2013115. doi: 10.2119\/molmed.2009.00119","journal-title":"Mol Med"},{"issue":"19","key":"1788_CR24","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/onc.2009.70","volume":"28","author":"F Cimmino","year":"2009","unstructured":"Cimmino F, Schulte JH, Zollo M, Koster J, Versteeg R, Iolascon A, Eggert A, Schramm A (2009) Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness. Oncogene 28(19):2015\u20132023. doi: 10.1038\/onc.2009.70","journal-title":"Oncogene"},{"issue":"47","key":"1788_CR25","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.3748\/wjg.v19.i47.8831","volume":"19","author":"ML Bacigalupo","year":"2013","unstructured":"Bacigalupo ML, Manzi M, Rabinovich GA, Troncoso MF (2013) Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma. World J Gastroenterol 19(47):8831\u20138849. doi: 10.3748\/wjg.v19.i47.8831","journal-title":"World J Gastroenterol"},{"issue":"10","key":"1788_CR26","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/ijc.26290","volume":"130","author":"D Tang","year":"2012","unstructured":"Tang D, Yuan Z, Xue X, Lu Z, Zhang Y, Wang H, Chen M, An Y, Wei J, Zhu Y, Miao Y, Jiang K (2012) High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer. Int J Cancer 130(10):2337\u20132348. doi: 10.1002\/ijc.26290","journal-title":"Int J Cancer"},{"issue":"3","key":"1788_CR27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1535-6108(04)00024-8","volume":"5","author":"N Rubinstein","year":"2004","unstructured":"Rubinstein N, Alvarez M, Zwirner NW, Toscano MA, Ilarregui JM, Bravo A, Mordoh J, Fainboim L, Podhajcer OL, Rabinovich GA (2004) Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell 5(3):241\u2013251","journal-title":"Cancer Cell"},{"issue":"3","key":"1788_CR28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.03.004","volume":"36","author":"GA Rabinovich","year":"2012","unstructured":"Rabinovich GA, Croci DO (2012) Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 36(3):322\u2013335. doi: 10.1016\/j.immuni.2012.03.004","journal-title":"Immunity"},{"issue":"3","key":"1788_CR29","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.1002940","volume":"186","author":"PL Kuo","year":"2011","unstructured":"Kuo PL, Hung JY, Huang SK, Chou SH, Cheng DE, Jong YJ, Hung CH, Yang CJ, Tsai YM, Hsu YL, Huang MS (2011) Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3\/IL-10 signaling pathway. J Immunol 186(3):1521\u20131530. doi: 10.4049\/jimmunol.1002940","journal-title":"J Immunol"},{"issue":"32","key":"1788_CR30","doi-asserted-by":"crossref","first-page":"13134","DOI":"10.1073\/pnas.0706017104","volume":"104","author":"P Juszczynski","year":"2007","unstructured":"Juszczynski P, Ouyang J, Monti S, Rodig SJ, Takeyama K, Abramson J, Chen W, Kutok JL, Rabinovich GA, Shipp MA (2007) The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci USA 104(32):13134\u201313139. doi: 10.1073\/pnas.0706017104","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"1788_CR31","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1158\/0008-5472.CAN-10-4157","volume":"71","author":"A Banh","year":"2011","unstructured":"Banh A, Zhang J, Cao H, Bouley DM, Kwok S, Kong C, Giaccia AJ, Koong AC, Le QT (2011) Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis. Cancer Res 71(13):4423\u20134431. doi: 10.1158\/0008-5472.CAN-10-4157","journal-title":"Cancer Res"},{"issue":"35","key":"1788_CR32","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1200\/JCO.2005.02.0206","volume":"23","author":"QT Le","year":"2005","unstructured":"Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, Zhao S, Kong C, Richardson D, O\u2019Byrne KJ, Giaccia AJ, Koong AC (2005) Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23(35):8932\u20138941. doi: 10.1200\/JCO.2005.02.0206","journal-title":"J Clin Oncol"},{"issue":"1","key":"1788_CR33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH730>3.0.CO;2-2","volume":"193","author":"FA Brule van den","year":"2001","unstructured":"van den Brule FA, Waltregny D, Castronovo V (2001) Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J Pathol 193(1):80\u201387. doi: 10.1002\/1096-9896(2000)9999:9999<:AID-PATH730>3.0.CO;2-2","journal-title":"J Pathol"},{"issue":"5","key":"1788_CR34","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1182\/blood-2006-04-016451","volume":"109","author":"MI Garin","year":"2007","unstructured":"Garin MI, Chu CC, Golshayan D, Cernuda-Morollon E, Wait R, Lechler RI (2007) Galectin-1: a key effector of regulation mediated by CD4\u00a0+\u00a0CD25\u00a0+\u00a0T cells. Blood 109(5):2058\u20132065. doi: 10.1182\/blood-2006-04-016451","journal-title":"Blood"},{"issue":"8","key":"1788_CR35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ni1482","volume":"8","author":"MA Toscano","year":"2007","unstructured":"Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, Zwirner NW, Poirier F, Riley EM, Baum LG, Rabinovich GA (2007) Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 8(8):825\u2013834. doi: 10.1038\/ni1482","journal-title":"Nat Immunol"},{"issue":"8","key":"1788_CR36","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/onc.2009.416","volume":"29","author":"F Pages","year":"2010","unstructured":"Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH (2010) Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29(8):1093\u20131102. doi: 10.1038\/onc.2009.416","journal-title":"Oncogene"},{"issue":"1","key":"1788_CR37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-010-0831-1","volume":"125","author":"S Ladoire","year":"2011","unstructured":"Ladoire S, Arnould L, Mignot G, Coudert B, Rebe C, Chalmin F, Vincent J, Bruchard M, Chauffert B, Martin F, Fumoleau P, Ghiringhelli F (2011) Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat 125(1):65\u201372. doi: 10.1007\/s10549-010-0831-1","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1788_CR38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.2006.08.9755","volume":"25","author":"RC Taylor","year":"2007","unstructured":"Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS (2007) Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol 25(7):869\u2013875. doi: 10.1200\/JCO.2006.08.9755","journal-title":"J Clin Oncol"},{"issue":"10","key":"1788_CR39","first-page":"3137","volume":"8","author":"TE Reichert","year":"2002","unstructured":"Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL (2002) Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 8(10):3137\u20133145","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1788_CR40","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.ejca.2010.02.046","volume":"46","author":"A Kyrgidis","year":"2010","unstructured":"Kyrgidis A, Tzellos TG, Kechagias N, Patrikidou A, Xirou P, Kitikidou K, Bourlidou E, Vahtsevanos K, Antoniades K (2010) Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival. Eur J Cancer 46(9):1563\u20131572. doi: 10.1016\/j.ejca.2010.02.046","journal-title":"Eur J Cancer"},{"issue":"5","key":"1788_CR41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/bjc.1984.239","volume":"50","author":"A Csiba","year":"1984","unstructured":"Csiba A, Whitwell HL, Moore M (1984) Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms. Br J Cancer 50(5):699\u2013709","journal-title":"Br J Cancer"},{"issue":"8","key":"1788_CR42","first-page":"1427","volume":"2","author":"B Seliger","year":"1996","unstructured":"Seliger B, Hohne A, Knuth A, Bernhard H, Ehring B, Tampe R, Huber C (1996) Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression. Clin Cancer Res 2(8):1427\u20131433","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1788_CR43","first-page":"1756","volume":"56","author":"B Seliger","year":"1996","unstructured":"Seliger B, Hohne A, Knuth A, Bernhard H, Meyer T, Tampe R, Momburg F, Huber C (1996) Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res 56(8):1756\u20131760","journal-title":"Cancer Res"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1788-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-015-1788-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1788-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T09:05:46Z","timestamp":1567501546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-015-1788-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,12]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1788"],"URL":"https:\/\/doi.org\/10.1007\/s00262-015-1788-z","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,12]]}}}